Elevated circulating fibrocyte levels in patients with hypertensive heart disease

Journal of Hypertension

Volumn 30, Issue 9, 2012, Pages 1856-1861

  Keeley, Ellen C ^a   Mehrad, Borna ^b   Janardhanan, Rajesh ^a   Salerno, Michael ^a   Hunter, Jennifer R ^a   Burdick, Marie M ^b   Field, Joshua J ^c   Strieter, Robert M ^b   Kramer, Christopher M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Department of Internal Medicine ^*  (United States)

^c BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

cardiac MRI; fibrocyte; fibrosis; hypertensive heart disease; left ventricular hypertrophy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GADOLINIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD; CARDIOVASCULAR MAGNETIC RESONANCE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIURETIC THERAPY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERTENSION; HYPERTENSIVE HEART DISEASE; MALE; NON INVASIVE PROCEDURE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 84865479305     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835639bb     Document Type: Article

References (38)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics: 2011 update-a report from the American Heart Association. Circulation 2011; 123:e18-e209.
2. Drazner MH. The progression of hypertensive heart disease. Circulation 2011; 123:327-334.
3. Diez J, Gonzalez A, Lopez B, Querejeta R. Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease. Nat Clin Pract Cardiovasc Med 2005; 2:209-216. (Pubitemid 40812484)
4. Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 1993; 27:341-348. (Pubitemid 23116130)
5. Diez J, Frohlich ED. A translational approach to hypertensive heart disease. Hypertension 2010; 55:1-8.
6. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 2008; 358:1370-1380.
7. Rossi MA. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens 1998; 16:1031-1041. (Pubitemid 28367959)
8. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Hamashima Y, Kawai C. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J 1986; 55:575-581. (Pubitemid 16092908)
9. Huysman JA, Vliegen HW, Van der Laarse A, Eulderink F. Changes in nonmyocyte tissue composition associated with pressure overload of hypertrophic human hearts. Pathol Res Pract 1989; 184:577-581. (Pubitemid 19169093)
10. Pearlman ES, Weber KT, Janicki JS, Pietra GG, Fishman AP. Muscle fiber orientation and connective tissue content in the hypertrophied human heart. Lab Invest 1982; 46:158-164. (Pubitemid 12181056)
11. McLenachan JM, Dargie HJ. Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. Am J Hypertens 1990; 3:735-740. (Pubitemid 20345997)
12. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117:568-575. (Pubitemid 46348511)
13. Keeley EC, Mehrad B, Strieter RM. The role of fibrocytes in fibrotic diseases of the lungs and heart. Fibrogenesis Tissue Repair 2011; 4:2.
14. Keeley EC, Mehrad B, Strieter RM. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol 2010; 42:535-542.
15. Keeley EC, Mehrad B, Strieter RM. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders. Thromb Haemost 2009; 101:613-618.
16. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1:71-81.
17. Andersson-Sjoland A, de Alba CG, Nihlberg K, Becerril C, Ramirez R, Pardo A, et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008; 40:2129-2140.
18. Mehrad B, Burdick MD, Strieter RM. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. Int J Biochem Cell Biol 2009; 41:1708-1718.
19. Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, Strieter RM. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 2007; 353: 104-108. (Pubitemid 44958347)
20. Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179:588-594.
21. Sakai N, Wada T, Matsushima K, Bucala R, Iwai M, Horiuchi M, et al. The renin-angiotensin system contributes to renal fibrosis through regulation of fibrocytes. J Hypertens 2008; 26:780-790. (Pubitemid 351354927)
22. Mollmann H, Nef HM, Kostin S, von Kalle C, Pilz I, Weber M, et al. Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc Res 2006; 71:661-671. (Pubitemid 44848010)
23. van Amerongen MJ, Bou-Gharios G, Popa E, van Ark J, Petersen AH, van Dam GM, et al. Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J Pathol 2008; 214:377-386. (Pubitemid 351212393)
24. Chu PY, Mariani J, Finch S, McMullen JR, Sadoshima J, Marshall T, et al. Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am J Pathol 2010; 176:1735-1742.
25. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004; 114:438-446. (Pubitemid 39071616)
26. Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004; 36:598-606. (Pubitemid 38316817)
27. Chauhan H, Abraham A, Phillips JR, Pringle JH, Walker RA, Jones JL. There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. J Clin Pathol 2003; 56:271-276. (Pubitemid 36459796)
28. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003; 171:380-389. (Pubitemid 36745311)
29. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 2007; 170:1807-1816. (Pubitemid 47339255)
30. Scotton CJ, Chambers RC. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 2007; 132:1311-1321. (Pubitemid 47621009)
31. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001; 166:7556-7562. (Pubitemid 32525636)
32. Haudek SB, Cheng J, Du J, Wang Y, Hermosillo-Rodriguez J, Trial J, et al. Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J Mol Cell Cardiol 2010; 49:499-507.
33. Xu J, Lin SC, Chen J, Miao Y, Taffet GE, Entman ML, et al. CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis. Am J Physiol Heart Circ Physiol 2011; 301:H538-H547.
34. Janardhanan R, Kramer CM. Imaging in hypertensive heart disease. Expert Rev Cardiovasc Ther 2011; 9:199-209.
35. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-618. (Pubitemid 8066109)
36. Gomperts BN, Strieter RM. Fibrocytes in lung disease. J Leukoc Biol 2007; 82:449-456. (Pubitemid 47367134)
37. Metz CN. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 2003; 60:1342-1350. (Pubitemid 36900518)
38. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010; 122:138-144.